Be the cure
Be the cure
Be the
Change a life
Change a life
Change a
Join our team
Join our team
Join our

The expertise to create cures and life-changing treatments

Assembly Bio is passionately applying scientific ingenuity, and a deep knowledge of virology to find a cure for hepatitis B (HBV), one of the world’s most prevalent and devastating infectious diseases. At the same time, we are advancing a microbiome portfolio of live biotherapeutics capable of transforming lives in a broad range of tough-to-treat conditions. Be a part of our ambitious and caring life’s work. Together, we have the potential to change lives.

In the News
July 09, 2020
Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H2158 for the Treatment of Chronic Hepatitis B Virus Infection
July 02, 2020
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 25, 2020
Assembly Biosciences Initiates Phase 2 Trial Evaluating Second-Generation Core Inhibitor ABI-H2158 for Chronic Hepatitis B Infection
    Tech in lab

    It’s time to end the deadly Hepatitis B virus that has killed more than 800,000 people a year, including my own family members. I’m encouraged by the efforts of Assembly Bio to develop better treatments that could lead to a cure.”

    — Alan Wang, Emmy award-winning television news anchor.
    Infected at birth with chronic Hepatitis B.